Diamonds and Dogs


Every dog has its day. The rollercoaster ride continues as Valeant Pharmaceuticals (VRX) jumped 10% on positive news for once.  A special board committee completed an internal investigation without discovering additional financial fallout from the firm's previous ties to a controversial pharmacy company, Philidor. Valeant also said they plan to meet a key April 29 filing deadline required to avoid potential default on debt obligations. Even with today's rebound, the stock is still down 72% year-to-date.

The government strikes down another one. Ireland based drug company, Allergan (AGN) saw its stock drop $41 or 15% after the Treasury Department created a new rule that threatens the company's proposed merger of Pfizer. Last year the company announced that it would merge with Pfizer and move its operations to Ireland. The move would create one of the biggest tax inversions ever, but the US government or the US Treasury says enough is enough. Looks like these deals will be tougher to create going forward.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.